Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Epilepsy drug vormatrigine moves to long-term safety check in 700 adults

NCT ID NCT07287163

First seen Dec 26, 2025 · Last updated May 24, 2026 · Updated 22 times

Summary

This study is checking the long-term safety of the drug vormatrigine in 700 adults who have epilepsy with focal or generalized tonic-clonic seizures. All participants have already taken vormatrigine in a previous study. The main goal is to see how safe and tolerable the drug is over time by monitoring side effects, vital signs, and lab results.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOCAL SEIZURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Praxis Research Site

    Miami Lakes, Florida, 33016, United States

  • Praxis Research Site

    Naples, Florida, 34116, United States

  • Praxis Research Site

    Lafayette, Louisiana, 70508, United States

  • Praxis Research Site

    Bethesda, Maryland, 20817, United States

  • Praxis Research Site

    Chesterfield, Missouri, 63005, United States

  • Praxis Research Site

    Amherst, New York, 14226, United States

  • Praxis Research Site

    Middletown, New York, 10941, United States

  • Praxis Research Site

    El Paso, Texas, 79912, United States

  • Praxis Research Site

    Houston, Texas, 77058, United States

  • Praxis Research Site

    Bielefeld, 33617, Germany

  • Praxis Research Site

    Tübingen, 72076, Germany

  • Praxis Research Site

    Milan, 20133, Italy

  • Praxis Research Site

    Pavia, 27100, Italy

  • Praxis Research Site

    Bydgoszcz, 85163, Poland

  • Praxis Research Site

    Katowice, 40123, Poland

  • Praxis Research Site

    Barcelona, 08003, Spain

  • Praxis Research Site

    Madrid, 28040, Spain

  • Praxis Research Site

    Málaga, 29010, Spain

  • Praxis Research Site

    Terrassa, 08222, Spain

  • Praxis Research Site

    Valencia, 46026, Spain

Conditions

Explore the condition pages connected to this study.